Published in Environ Mol Mutagen on January 01, 2003
Significance of micronucleus in cervical intraepithelial lesions and carcinoma. J Cytol (2012) 0.90
Association between cervical lesion grade and micronucleus frequency in the Papanicolaou test. Genet Mol Biol (2014) 0.86
How virus persistence can initiate the tumorigenesis process. World J Virol (2013) 0.84
Association between micronucleus frequency and cervical intraepithelial neoplasia grade in Thinprep cytological test and its significance. Int J Clin Exp Pathol (2015) 0.80
Evaluation of cell types for assessment of cytogenetic damage in arsenic exposed population. Mol Cancer (2008) 0.79
Association between human papillomavirus (HPV) DNA and micronuclei in normal cervical cytology. Genet Mol Biol (2014) 0.76
Planning cancer control in Latin America and the Caribbean. Lancet Oncol (2013) 8.43
Frequency and genotype distribution of multiple human papillomavirus infections in cancer of the head and neck in a Mexican population. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 1.99
Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis (2005) 1.85
The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. Mutat Res (2008) 1.66
Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer (2011) 1.53
Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. Cancer Epidemiol Biomarkers Prev (2004) 1.34
Breast cancer in Mexico: a growing challenge to health and the health system. Lancet Oncol (2012) 1.19
Primary synovial sarcoma of the kidney: corroboration with in situ polymerase chain reaction. Ann Diagn Pathol (2007) 1.14
Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study. Int J Radiat Oncol Biol Phys (2005) 1.11
Role of infectious diseases in human carcinogenesis. Environ Mol Mutagen (2005) 0.99
Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix. Gynecol Oncol (2005) 0.98
Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico. Cancer (2014) 0.97
Glutathione depletion activates mitogen-activated protein kinase (MAPK) pathways that display organ-specific responses and brain protection in mice. Free Radic Biol Med (2007) 0.97
Colorectal cancer in Mexico: should a middle income country invest in screening or in treatment? Eur J Health Econ (2010) 0.94
Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients. Exp Diabetes Res (2012) 0.93
Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population. Gynecol Oncol (2006) 0.92
Geographical variation in human papillomavirus prevalence in Mexican women with normal cytology. Int J Infect Dis (2010) 0.90
Human papilloma virus in oral squamous cell carcinoma in a Mexican population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 0.90
Validation of the Mexican-Spanish version of the EORTC QLQ-C15-PAL questionnaire for the evaluation of health-related quality of life in patients on palliative care. Psychooncology (2010) 0.88
Arsenic and lead contamination in urban soils of Villa de la Paz (Mexico) affected by historical mine wastes and its effect on children's health studied by micronucleated exfoliated cells assay. Environ Geochem Health (2012) 0.88
Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions. Hum Pathol (2003) 0.87
The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study. Virol J (2007) 0.87
Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer. PLoS One (2012) 0.87
Breast cancer in young women in Latin America: an unmet, growing burden. Oncologist (2013) 0.87
Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication therapy. Cancer Epidemiol Biomarkers Prev (2006) 0.86
Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma. Am J Clin Oncol (2003) 0.86
The role of amino acid transporters in GSH synthesis in the blood-brain barrier and central nervous system. Neurochem Int (2012) 0.83
Neoadjuvant chemotherapy followed by surgery in locally advanced cervical carcinoma. J Clin Oncol (2002) 0.83
The glutathione system and its regulation by neurohormone melatonin in the central nervous system. Cent Nerv Syst Agents Med Chem (2010) 0.83
Cell proliferation and inflammation on biopsy samples with multifocal atrophic gastritis before and 1 year after Helicobacter pylori eradication. Arch Pathol Lab Med (2005) 0.82
Functional implication of sequence variation in the long control region and E2 gene among human papillomavirus type 18 variants. Arch Virol (2009) 0.81
Induction of p53 up-regulated modulator of apoptosis messenger RNA by chemotherapeutic treatment of locally advanced breast cancer. Clin Cancer Res (2005) 0.81
Intratypic changes of the E1 gene and the long control region affect ori function of human papillomavirus type 18 variants. J Gen Virol (2012) 0.81
[Usefulness of combining universal oligonucleotides in detecting human papillomavirus in cervical cancer and premalignant lesions]. Salud Publica Mex (2004) 0.81
Changing risk factors for HIV infection. Arch Med Res (2002) 0.80
The MAD1 1673 G → A polymorphism alters the function of the mitotic spindle assembly checkpoint and is associated with a worse response to induction chemotherapy and sensitivity to treatment in patients with advanced epithelial ovarian cancer. Pharmacogenet Genomics (2013) 0.79
It is time to include cancer and other noncommunicable diseases in the millennium development goals. CA Cancer J Clin (2009) 0.79
Whole-brain irradiation with concomitant daily fixed-dose temozolomide for brain metastases treatment: a randomised phase II trial. Radiother Oncol (2012) 0.79
The GSTM1null (deletion) and MGMT84 rs12917 (Phe/Phe) haplotype are associated with bulky DNA adduct levels in human leukocytes. Mutat Res (2013) 0.78
[Metalloproteinase (MMP-1, 2 and 11), tissue inhibitor of metalloproteinase-1 (TIMP-1), and p53 expression in nasal-type angiocentric T/NK-cell lymphoma: an immunohistochemical study]. Gac Med Mex (2005) 0.77
Breast cancer in young women in Latin America: an unmet, growing burden. Oncologist (2013) 0.77
Polyurethane II catheter as long-indwelling intravenous catheter in patients with cancer. Am J Infect Control (2003) 0.77
Costs of breast cancer treatment prior to the introduction of immune-based therapy in Mexico. Rev Med Inst Mex Seguro Soc (2012) 0.77
Impact of a federal program on response rate & survival, in a cohort of patients with diffuse large B-cell lymphoma. Analysis in a single national reference institution in México. Rev Invest Clin (2015) 0.76
[Main malignant neoplasms in Mexico and their geographic distribution, 1993-2002]. Rev Invest Clin (2012) 0.76
Access to care issues adversely affect breast cancer patients in Mexico: oncologists' perspective. BMC Cancer (2014) 0.75
Treatment outcomes and prognostic factors in mexican patients with endometrial carcinoma with emphasis on patients receiving radiotherapy after surgery: an institutional perspective. ISRN Oncol (2012) 0.75
Long-term results of paclitaxel in FIGO stage III ovarian carcinoma. Anticancer Drugs (2003) 0.75
[Ovarian cancer; will the new challenge in gynecologic oncology?]. Rev Invest Clin (2013) 0.75
Multimodal treatment of locally advanced cervical cancer. Arch Med Res (2005) 0.75
Transfusion-associated HIV infection in Mexico related to paid blood donors; HIV epidemic. Int J STD AIDS (2004) 0.75
[Genetic material: instruction manual for the management of disease; breast cancer, for example]. Rev Invest Clin (2002) 0.75
Cervical cancer prevention: the case of developing countries. Salud Publica Mex (2003) 0.75